Ibutamoren: A Comprehensive Overview of its Nootropic Properties
Ibutamoren, also known as MK-677, is a nootropic drug that has been gaining popularity in recent years due to its purported cognitive-enhancing effects. It is a growth hormone secretagogue, meaning it stimulates the release of growth hormone from the pituitary gland. It is also known to increase levels of insulin-like growth factor 1 (IGF-1) in the body. In this article, we will discuss the potential benefits and risks of taking Ibutamoren, as well as its history and dosage information.
Ibutamoren is a non-peptide, orally active, and selective agonist of the ghrelin receptor. It is a growth hormone secretagogue, meaning it stimulates the release of growth hormone from the pituitary gland. It is also known to increase levels of insulin-like growth factor 1 (IGF-1) in the body. It is a synthetic drug that is not approved for human use, but is available as a research chemical.
- Increases growth hormone levels
- Increases IGF-1 levels
- Improves sleep quality
- Improves cognitive function
- Increases muscle mass
- Improves bone density
- Improves skin health
Possible Negative Effects
- Increased appetite
- Joint pain
- Water retention
- Increased risk of cancer
The recommended dosage of Ibutamoren is 25-50 mg per day. It is best to start with a lower dose and gradually increase it over time. It is important to note that Ibutamoren should not be taken for more than 12 weeks at a time, as it can cause long-term side effects.
Ibutamoren was first developed in the 1990s by a pharmaceutical company in Japan. It was initially developed as a treatment for growth hormone deficiency, but it was never approved for human use. In recent years, it has gained popularity as a nootropic drug due to its purported cognitive-enhancing effects. It is now available as a research chemical.